Unraveling a Diagnostic Enigma: A TECPR2 Case Solved Through Multi-Omic Genomics.

Am J Med Genet AMay 11, 2026 (epub)
Case ReportMedical Genetics

Teresa Zhao, Andrew P Fennell, Tanavi Sharma et al.

✦ AI-curated · Sources linked

Case in brief

A teenage female presented with syndromic intellectual disability and neuromuscular abnormalities. Multi-omics analysis, including genomics, transcriptomics, and proteomics, was employed alongside muscle biopsy. Trio exome sequencing revealed two heterozygous variants in the TECPR2 gene, initially classified as variants of uncertain significance. Long-read sequencing confirmed the variants were in trans, and functional studies established their pathogenicity, leading to a definitive diagnosis.

Diagnostic / clinical pearl

This case highlights the importance of multi-omics analysis in resolving complex genetic disorders, particularly when traditional methods yield uncertain results.

Why it matters

Utilizing a multi-omics approach can enhance diagnostic accuracy in cases of hereditary sensory and autonomic neuropathies, potentially guiding future management strategies.

Source

Published in Am J Med Genet A. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Medical Genetics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.